Ousia Pharma ApS

CVR 43055909 · Private limited company (ApS) · Active · Low risk

Ousia Pharma ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.2 times the average for Danish companies. 4 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 11.8m and a net result of DKK -12.8m. CEO: Christoffer Clemmensen, Jonas Odgaard Petersen, Anders Bue Klein.

Bankruptcy risk for Ousia Pharma ApS

0.2%
probability of bankruptcy within 12 months
Low risk

0.2 × the average (1.41%) · higher risk than 49% of active Danish companies

Lowest riskHighest risk

Increases the risk

Return on assets< -20% · bankruptcy rate 16.7%1.9×
Age (years)3–5 yrs · bankruptcy rate 13.3%1.5×
Published annual reports3–5 · bankruptcy rate 11.7%1.3×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×
Annual reports filed late1 · bankruptcy rate 11.3%1.3×
Time since new CEO2–5 yrs · bankruptcy rate 10.8%1.2×
Share of late annual reports25%–50% · bankruptcy rate 10.6%1.2×

Reduces the risk

Current ratio500%+ · bankruptcy rate 1.5%0.17×
Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Number of CEOs3+ · bankruptcy rate 4.0%0.46×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Negative equityNo · bankruptcy rate 5.1%0.58×
Capital changes2 · bankruptcy rate 5.2%0.59×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
43055909
Status
Active
Company type
Private limited company (ApS)
Founded
(4 years)
Address
Ole Maaløes Vej 3
2200 København N
Municipality
København
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 100k
Auditor
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
Audit opted out
No

Warning signs

Annual reports filed late1 of 4
Missing annual reportNo
Negative equityNo
Equity ratio94.6%
Current ratio1,837%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address167
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK -10.2mDKK -3.7m
Net profitDKK -12.8mDKK -5.3m
EquityDKK 11.8mDKK -10.1m
Total assetsDKK 12.5mDKK 5.1m
CashDKK 10.2m–
Short-term debtDKK 680k–
Avg. employees8–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025183
1 Jan 2024 – 31 Dec 2024170
1 Jan 2023 – 31 Dec 2023181
14 Feb 2022 – 31 Dec 202288

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOChristoffer ClemmensenCurrent
CEOJonas Odgaard PetersenCurrent
CEOAnders Bue KleinCurrent
BoardOtello StampacchiaCurrent
BoardMenelas Nicolas PangalosCurrent
BoardRamesh Rajanikant BhattCurrent
BoardGaurav GuptaCurrent
BoardIan Rodney Laquian
BoardMikael Søndergaard Thomsen
BoardJeppe Ragnar Andersen
BoardMorten Peltola Toft
BoardChristoffer Clemmensen
BoardJonas Odgaard Petersen
BoardAnders Bue Klein
BoardMargareta Elisabeth Björk
Owner (100%)JLSa2 Therapeutics, Inc.Current
Owner (33%)Science Studio Holding ApS
Owner (33%)Nordic Alchemy Holding ApS
Owner (33%)Klein Science Holding ApS
Owner (10%)BioInnovation Institute Fonden
Owner (15%)Science Studio Holding ApS
Owner (15%)Nordic Alchemy Holding ApS
Owner (15%)Klein Science Holding ApS
Owner (15%)Omega Fund VIII, L.P
Owner (10%)BII Holdings A/S
Owner (5%)BII Holdings A/S
Owner (10%)Science Studio Holding ApS
Owner (10%)Nordic Alchemy Holding ApS
Owner (10%)Klein Science Holding ApS
Owner (33%)Omega Fund VIII, L.P
AuditorPRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKABCurrent
FounderScience Studio Holding ApSCurrent
FounderNordic Alchemy Holding ApSCurrent
FounderKlein Science Holding ApSCurrent

The CEOs' other companies

Christoffer Clemmensen – 2 other companies

Jonas Odgaard Petersen – 2 other companies

Anders Bue Klein – 1 other companies

Address history (0 moves)

Ole Maaløes Vej 3, 2200 København N

Former names

Ousia Pharma ApS – now
Ouisa Pharma ApS –

Other companies at the same address

Similar companies in København

Questions and answers about Ousia Pharma ApS

Has Ousia Pharma ApS gone bankrupt?

No, Ousia Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Ousia Pharma ApS?

Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.2 times the average for Danish companies.

Who is the CEO of Ousia Pharma ApS?

Christoffer Clemmensen, Jonas Odgaard Petersen, Anders Bue Klein are the CEOs of Ousia Pharma ApS.

Who is the auditor of Ousia Pharma ApS?

Ousia Pharma ApS most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.

When was Ousia Pharma ApS founded?

Ousia Pharma ApS was founded on 14 February 2022.

What is the equity of Ousia Pharma ApS?

Equity was DKK 11.8m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.